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Abstract 
Background 
Emerging adulthood is often-overlooked in current gastrointestinal (GI) health research; 
however, epidemiological evidence suggests that GI disorders are increasing in this population. 
The Rome IV criteria have taken a biopsychosocial approach to better understand the etiology of 
functional gastrointestinal disorders (FGID). Therefore, exploring biopsychosocial factors 
associated with GI functioning in emerging adults is warranted. The purpose of this study was to 
first define common GI symptom subgroups within emerging adults and then to characterize 
these group differences with key biopsychosocial factors encompassing diet, depression and 
anxiety symptoms, as well as physical and social functioning related to quality of life.  
Methods 
A total of 956 emerging adults from a southeastern US university were recruited. 
Participants completed a comprehensive survey on GI symptoms, psychosocial factors and 
demographics. Scores derived from the National Institutes of Health (NIH) Patient-Reported 
Outcomes Measurement Information System (PROMIS®) GI symptoms scales were used for 
latent class analyses. The most parsimonious number of classes were identified using Bayesian 
Information Criterion. A multivariate analysis of variance (MANOVA) was conducted 
comparing the differences in latent classes to key biopsychosocial factors. 
Results 
Latent class analysis uncovered three statistically significant GI symptom patterns within 
the sample identified by the degree of severity: Normal (649 individuals, 64.15% of the sample), 
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Mild (257 individuals, 30.30% of the sample), and Moderate (50 individuals, 5.55% of the 
sample). Chi-square analysis indicated that the groups differed in biological sex. Next, results 
from the MANOVA indicated that the 3 latent classes were significantly different on most of the 
biopsychosocial factors, F(8, 1896) = 25.909, p < .001, Pillai’s V = .155, partial η2 = .077.   
Conclusions 
The majority of this study’s sample had low scores on the various PROMIS GI measures 
and thus were considered to have healthy GI functioning. However, a surprisingly large 
proportion of the sample reported mild and moderate GI symptom severity. Latent classes 
identified 3 groups: Normal (n=649), Mild (n=257), and Moderate (n=50). These groups were 
different based on symptom levels but also biopsychosocial factors. Notably, the anxiety and 
depression levels increased with GI symptom levels. In fact, the Moderate group met clinical 
cutoffs on several measures. This study demonstrated that significant impairment in GI 
functioning emerges at much earlier ages that is commonly assumed. In addition, these GI 
symptom levels were associated with important biopsychosocial factors. Assessing GI 
functioning in emerging adults may provide important insights into understanding the 
development of FGIDs.  
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 1 
Introduction 
There are few studies assessing the prevalence of functional gastrointestinal disorders 
(FGIDs) in the general population. According to the data available, between 10% and 25% of the 
general US population meet the diagnostic criteria for an FGID (Agréus, Svärdsudd, Nyrén, & 
Tibblin, 1995; Drossman et al., 1993; Jones & Lydeard, 1992; Wilson, Roberts, Roalfe, Bridge, 
& Singh, 2004). Thirty percent of individuals experiencing a GI symptom will seek primary 
medical care (Drossman et al., 1993; Hungin, Chang, Locke, Dennis, & Barghout, 2005) and of 
those patients, 80% will be diagnosed with a FGID (Hungin et al., 2005). As of 2017, over 40% 
of patients consulting a gastroenterology specialist do so in reference to functional 
gastrointestinal disorders (Lacy & Patel, 2017).  
Generally, emerging adults (age 18-25) are viewed as a physically healthy cohort 
(Institute of Medicine and National Research Council, 2015) and consequently often-overlooked 
in current gastrointestinal (GI) health research. Newer epidemiological studies suggest that 
FGIDs are increasing in emerging adults (Harris, 2010; Kappelman, 2013; Trivedi & Keefer, 
2015; Urlep, Blagus, & Orel, 2015). As many as 65% of emerging adults are experiencing 
symptoms (Lee, Mun, Lee, & Cho, 2011) and approximately one third are seeking medical care 
(Jafri, Yakoob, Jafri, Islam, & Ali, 2005).  
Emerging adulthood marks the shift from being dependent on a care provider to taking 
independent responsibility for seeking medical care (Institute of Medicine and National Research 
Council, 2013). Research indicate this population have decreased adherence to medication and 
attend fewer physician appointments (Harris, Gordon-Larsen, Chantala, & Udry, 2006; Trivedi 
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& Keefer, 2015). Furthermore, this period establishes fundamental health and self-care behaviors 
that carry forward into adulthood (Auerbach, Admon, & Pizzagalli, 2014; Dalton & Hammen, 
2018; Harris, 2010). Adverse health behaviors have been observed in the amount of sleep, 
cigarette use, drinking, exercise, and eating habits of emerging adults (Dalton & Hammen, 2018; 
Harris et al., 2006; Olson, Hummer, & Harris, 2017).  
The current understanding of FGIDs is supported with evidence that multidimensional 
interactions between biological, psychological, and social/environmental distress are involved in 
the onset and severity of FGIDs (Drossman, 2016; Engel, 1977). These associations have led to 
the adoption of a biopsychosocial model in the study of FGIDs (Drossman, 2016). Interestingly, 
a culmination of biopsychosocial changes occurs in the emerging adult population (Arnett, 2000; 
Trivedi & Keefer, 2015). However, detailed observations of GI and biopsychosocial functioning 
in emerging adults have not yet been investigated.  
The purpose of this study was to first define homogenous GI symptom subgroups within 
emerging adults and then to characterize their differences using key biopsychosocial factors 
encompassing diet, mood and anxiety disorders, and health related quality of life.  
 3 
Background 
The following literature highlights current theories and research on functional 
gastrointestinal disorders, diet and psychosocial factors within the emerging adult population.  
Functional Gastrointestinal Disorders: A Brief Overview 
History of FGIDs.  
The study of GI disorders was heavily impacted by the 17th century Cartesian beliefs that 
the mind and body are separate. Mind-body dualism deemphasized the importance of 
psychological variables to the etiology of many illnesses such as FGID. Those experiencing 
psychological distress about physical symptoms without any apparent morphological signs were 
quickly dismissed as exaggerating or psychosomatic. It wasn’t until the early 19th century when 
observations of emotions affecting gastric function were documented (Drossman, 2016). By the 
mid 20th century, several scientific studies had uncovered a direct relationship between emotions 
and changes in bowel function (Alvarez, 1949; Drossman, 1998; Drossman, 2016). Nevertheless, 
the 1960s re-emphasized the presence of biological markers in classifying GI illnesses and 
psychosocial factors were again discounted. This approach resulted in many gastrointestinal 
symptoms such as IBS to be classified as a “psychosomatic” disorder (Drossman, 2016).  
The emergence of the biopsychosocial model in the study of FGIDs. It wasn’t until the 
late 1970’s that a unified theory of biological and psychological interactions was offered: The 
biopsychosocial model (Engel, 1977). The biopsychosocial model defines illness as the 
combined “…product of biological, psychological, and social subsystems interacting at multiple 
levels” (Drossman, 2016, p. 1265). This approach leads researchers to not only measure 
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biological markers, but to also include variables such as health-related quality of life, patient 
perceptions and behaviors, symptom severity and daily function.  Another transformation in 
understanding GI disorders occurred through the development of the field of 
neurogastroenterology in the 1990s (Drossman, 2016). Neurogastroenterology employed the 
latest technology to provide scientific evidence of the physiological interactions between the gut 
and brain, setting the foundation for the gut-brain axis model (Drossman, 2016). The gut-brain 
axis can be described as the system of “bidirectional communication between the central and the 
enteric nervous system, linking emotional and cognitive centers of the brain with peripheral 
intestinal functions” (Carabotti, Scirocco, Maselli, & Severi, 2015, p. 203).  
The 21st century marked a paradigm shift in defining the gut-brain axis with the emphasis 
on the role of the gut microbiota as a key physiological element in the development of FGIDs. 
Gut microbiota are the populations of microorganisms present in the body’s gastrointestinal tract 
(Evrensel & Ceylan, 2015, p. 239) and “engage in bidirectional communication with the brain 
via neural, endocrine, and immune pathways” (Van Oudenhove et al., 2016, p. 1362). These 
microorganisms have been associated with both the presentation of IBS symptoms and 
psychological disorders including anxiety and depression (Cryan, & Dinan, 2012; Van 
Oudenhove et al., 2016). The extent of these interactions has resulted in the emergence of the 
term microbiome-gut-brain axis (Van Oudenhove et al., 2016) thus expanding the conceptual 
framework of the gut-brain axis. Just as the field of gastroenterology expanded and evolved, so 
did the criteria for classifying and diagnosing GI disorders. 
Development of the diagnostic manual for FGIDs. The first major unified effort to 
produce a GI classification and diagnostic manual began in the late 1980s with the publication of 
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the Rome I criteria in 1994. The Rome I was the first comprehensive book aimed at identifying 
and describing GI disorders lacking in any visible organic abnormalities, such as IBS. In sync to 
the scientific community’s interpretation of GI disorders, the publishing of the Rome II criteria 
in 2000 officially coined the term neurogastroenterology, formalizing the field of gut-brain 
research (Kellow et al., 1999; Wood, Alpers, & Andrews, 1999). The Rome III criteria, 
published in 2006, utilized more evidence-based data to support GI classifications. The most 
recent version published in 2016, the Rome IV criteria, has undertaken the task of further 
redefining FGIDs based on the latest scientific discoveries along with providing the latest 
diagnostic and classification criteria (Schmulson & Drossman, 2017). According to the latest 
definition:  
FGIDs are disorders of gut–brain interaction. It is a group of disorders classified by GI 
symptoms related to any combination of the following: motility disturbance, visceral 
hypersensitivity, altered mucosal and immune function, altered gut microbiota, and 
altered central nervous system processing. (Drossman, 2016, p. 1268)  
In addition to changing the definition of FGIDs, the Rome IV criteria also added the 
microbiome, food, and nutrition as important elements in the study of GI function (Barbara et al., 
2016). Additionally, genetics and culture have been added to the current list of significant factors 
(age, gender, and women’s health) that impact GI disorders. Another key change in the Rome IV 
criteria was to officially adopt the biopsychosocial model, thus anchoring the new definition of 
FGIDs as disorders of gut-brain interaction. The biopsychosocial model emphasizes the 
interaction between all these diverse elements and their potential role in explaining the 
heterogeneity of GI disorders.  
 6 
The six FGID domains. 
The Rome IV criteria contains 6 primary FGID domains for adults encompassing over 33 
types of FGIDs and two domains dedicated to children. Each FGID is classified based on the 
patient’s report of symptom type and severity. A symptom is “…a noticeable experiential change 
in the body or its parts that is reported by the patient as being different from normal and may or 
may not be interpreted as meaningful” (Drossman, 2016, p. 1266). Functional GI disorders 
consider clusters of symptoms experienced together to describe a syndrome. A syndrome 
“…relates to the association of several clinically recognizable symptoms or signs that occur 
together to define a clinical entity” (Drossman, 2016, p. 1266). Therefore, FGIDs can be 
conceptualized as a “…syndrome based on symptoms that cluster together and are diagnosed by 
Rome criteria” (Drossman, 2016, p. 1266). Historically, individuals seek out medical support 
when they experience GI symptoms. Additionally, it is these symptoms that patients use to 
describe their illness to their clinician. Therefore, although FGIDs can include morphological 
changes or motility abnormalities, they are not the primary criteria used to classify an FGID 
(Drossman, 2016; Schmulson & Drossman, 2017). 
Notably new to the Rome IV criteria, FGIDs may be thought of as a “spectrum of chronic 
GI disorders with combinations of symptoms … existing on a continuum rather than as discrete 
disorders” (Simren, Palsson, & Whitehead, 2017, p. 4). Multiple studies support this new 
description by the Rome IV criteria providing scientific evidence that patients can transition 
from one disorder to another and can receive multiple diagnoses (Chey et al., 2015; Lacy et al., 
2016; Shah et al., 2018; Whitehead et al., 2002). However, the primary symptoms experienced is 
used to classify the six domains of FGIDs.  
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Table 1 FGID Domains According to the Rome IV Criteria.  
FGID Domains Primary Symptoms 
1. Esophageal Disorders Heartburn, chest pain, or reflex 
2. Gastroduodenal Disorders Dyspepsia, belching, nausea/vomiting 
3. Bowel Disorders Constipation, diarrhea, and gas/bloating 
4. Centrally Mediated Disorders of GI Pain Abdominal pain 
5. Gallbladder and Sphincter of Oddi Disorders Sudden pain usually experienced during gallstone or gallbladder attacks 
6. Anorectal Disorders Fecal incontinence and anorectal pain 
Note. (Drossman, 2016).   
 
One of the most studied FGID domains is Bowel Disorders which can be grouped into 6 
main categories. Additionally, four subcategories were created within the IBS category, the most 
frequently diagnosed GI disorder (Chey, Kurlander, & Eswaran, 2015) covering 11.2% of the 
world’s population (Lacy et al., 2016). 
Table 2 Bowel Disorder Categories.  
Bowel Disorders 
1. Irritable Bowel Syndrome (IBS) 
a. IBS-C: Predominant in constipation 
b. IBS-D: Predominant in diarrhea 
c. IBS-M: Mixed bowel habits 
d. IBS-U: Unclassified 
2. Functional Constipation 
3. Functional Diarrhea 
4. Functional Abdominal Bloating/Distention 
5. Unspecified Functional Bowel Disorders 
6. Opioid-induced Constipation 
Note. Simren, Palsson, & Whitehead, 2017 
 
Almario et al. evaluated FGID symptom prevalence within the general US adult 
population (n=71,812, ages 18-65) using the National Institutes of Health (NIH) Patient-
Reported Outcomes Measurement Information System (PROMIS®) GI scales (Almario et al., 
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2018). Eight overarching FGID symptom domains (abdominal pain, bloating/gas, bowel 
incontinence, constipation, diarrhea, swallowing, reflux, and nausea/vomiting) were assessed 
including the occurrence of overlapping symptoms. Over 61% of their study sample endorsed at 
least one symptom within the past 7 days. Of those, 58.4% indicated they experienced two or 
more symptoms concurrently. Based on their findings, close to 1/3 of their sample population 
experienced reflux/heartburn, making it the most prevalent symptom. One quarter reported 
abdominal pain and a fifth of the participants experienced bloating, diarrhea, and constipation. 
This study included emerging adults in their population sample, finding that over 54% (n=6,954) 
reported the occurrence of at least 1 FGID symptom within the past week. However, further 
descriptions of FGID symptoms within emerging adults were not provided.  
The most commonly studied FGID syndrome in emerging adults is IBS. According to the 
ACHA-National College Health Assessment II national survey for the Fall 2017 semester, 3.2% 
of the undergraduate students surveyed (n=5,789) had been diagnosed by a healthcare 
professional of having IBS (American College Health Association, 2017, pg. 3). Another study 
focused on recurrent abdominal pain (RAP) and IBS prevalence in emerging adults. The study 
concluded that those individuals who had higher levels of RAP also experienced higher rates of 
recurrence five years later for RAP and IBS, resulting in higher levels of functional disability, 
school absence, and clinic visits for abdominal stress (Walker, Guite, Duke, Barnard, & Greene, 
1998). A third study evaluated the frequency of IBS in college students demonstrating that 34% 
of the sample (n=508, mean age: 22+/-2.8yrs) experienced clinical symptoms (Jafri et al., 2005).  
This previous research demonstrated clinical rates of IBS in the emerging adult population but is 
 9 
limited in that it does not capture a broader range of general GI distress or subclinical 
symptomatology.  
GI symptoms are usually present before an FGID diagnosis is made and therefore serve 
as a likely reason for seeking medical care (Almario et al., 2018; Spiegel et al., 2014). However, 
fewer than 20% of the US population who experience GI symptoms will actually seek medical 
care (Sandler, Stewart, Liberman, Ricci, & Zorich, 2000). It therefore stands to reason that 
measuring GI symptoms within a healthy, non-clinical population rather than relying on 
clinically diagnosed cases may provide additional insight into the overall prevalence of GI 
distress. Additionally, FGIDs including IBS are considered heterogenous, not only in their 
diagnostic classification but also in their potential pathogenesis (Adam, Liebregts, & Holtman, 
2007; Jones, Van Oudenhove, & Talley, 2012). With that in mind, applying the biopsychosocial 
model to determine what factors are potentially responsible for FGIDs is needed. 
The Biopsychosocial Model of FGIDs 
Exploring the etiology of FGIDs expanded with the biopsychosocial model, providing 
researchers with a new conceptual framework that incorporated research from both psychosocial 
and biological fields. Specifically, the biopsychosocial model placed equal value in researching 
the patient’s reported experience of illness with the physical indicators of disease (Drossman & 
Dumitrascu, 2006), resulting in studies of a singular mind-body system. Consequently, 
researchers identified a bi-directional communication pathway between the mind and GI tract, 
termed the gut-brain axis (Drossman, 2016; Van Oudenhove et al., 2016). The gut-brain axis 
provided evidence that changes in either the mind or gut can disrupt the balance of the other. 
More specifically, biopsychosocial factors impacting the gut-brain axis could be traced to the 
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risk of developing GI symptoms, symptom severity, and affecting treatment outcomes 
(Drossman, 2016; Van Oudenhove et al., 2016).  
A closer look at the biopsychosocial factors involved in FGIDs reveal a diverse range of 
domains. At present, these include but are not limited to environmental, cultural, and 
psychosocial factors, including the composition of an individual’s gut microbiome, diet, and 
nutrition (Van Oudenhove et al., 2016). 
Figure 1 The Biopsychosocial Model 
 
 
Adapted from Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV. 
Gastroenterology. 150, 1262-1279 by D.A. Drossman, 2016. 
 
 
 
Environmental factors: childhood, trauma, & chronic stress. 
Environmental factors are important contributors to the lifespan development of an 
individual. The degree of susceptibility to FGIDs can be traced to early childhood development, 
where children learn to modify their behaviors in response to their parent’s reaction to their 
illness (Levy et al., 2004). Exposure to any form of abuse, whether psychological, physical, or 
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sexual, will increase the likelihood of experiencing an FGID (Bradford et al., 2012), specifically 
affecting symptom severity and clinical outcomes (Drossman, 2011). Furthermore, experiencing 
a major loss can influence the onset of an FGID (Bitton et al., 2008; Lackner & Gurtman, 2004; 
Sperber, Drossman, & Quigley, 2012). However, an environment with chronic and high levels of 
life stress has proven to be one of the strongest factors for developing FGIDs (Drossman et al., 
2000). Emerging adults are especially susceptible to chronic stress as they transition into 
adulthood (Cohen, Burt, & Bjorck, 1987; D’Zurilla & Sheedy, 1991). Stress provoking 
environments for emerging adults include attending college and adjusting to new social settings 
(Ross, Niebling, & Heckert, 1999). Consequently, the inability to properly cope with chronic 
stress frequently result in depression and maladaptive eating behaviors in emerging adults 
(Dalton & Hammen, 2018; McGonagle & Kessler, 1990).    
Environmental factors affecting FGIDs can occur at any point in life, ranging from early 
childhood conditioning, experiencing acute adverse events, to sustaining ongoing periods of 
stress. Environmental factors illustrate the multidimensional aspect of the biopsychosocial model 
because they not only influence the susceptibility to FGIDs, they can also foster psychological 
disorders.  
Psychosocial factors: mood disorders, anxiety disorders & quality of life. 
In addition to demonstrating the multidimensional aspect of FGIDs, the biopsychosocial 
model also accounts for the bi-directional communication pathways between domains, such as 
the gut-brain axis. The gut-brain axis is a defining representation of the relationship between 
psychosocial factors and FGIDs. Psychosocial disturbances can ignite the exacerbation of GI 
symptoms or they can be a consequence of experiencing GI symptoms (Van Oudenhove et al., 
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2016).  Additionally, psychosocial factors have great influence over whether someone will seek 
medical care and also over the effectiveness of treatment (Drossman, 2016). According to the 
latest Rome IV overview, psychosocial factors associated with the gut-brain axis that interact 
with the development and severity of FGIDs include mood disorders (depression and suicide 
ideation), anxiety disorders, somatization, and cognitive-affective processes (Van Oudenhove et 
al., 2016).  
Based on a systematic review, when patients’ GI symptoms are categorized into mild, 
moderate, or severe levels discrete associations with levels of care and psychosocial variables 
emerge (Drossman et al., 2011; Drossman, 2016). For example, 40% of patients who endorse 
mild GI symptoms are commonly treated in primary care settings and psychological disorders 
are not elevated and the general quality of life is good (Drossman, 2016). In comparison, 
approximately 30%-35% of patients will meet the criteria for moderate GI symptoms. This 
segment will experience a stronger association between their social environment, psychological 
distress and abdominal pain, creating some interference in daily activity. Finally, individuals 
with severe GI symptom levels make up 20%-25% of patients and are more frequently seen by a 
gastroenterologist. Individuals experiencing severe GI symptoms also experience high levels of 
anxiety, depression, and/or personality disorders. Additionally, history of abuse, major loss, and 
poor social networks are strongly associated with this group. Furthermore, these individuals 
experience frequent disruptions in their daily activity due to their GI symptoms (Drossman, 
2016). These findings need to be replicated in general non-patient populations. 
Anxiety disorders are closely associated with the onset and duration of FGIDs. Studies 
have found that anxiety disorders are directly associated with the biological stress response 
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processes, and as a result, can alter pain tolerance and motility (Van Oudenhove et al., 2016). In 
a sample of 604 college students (age= 20.93 ± 1.47 years), 36.9% endorsed IBS symptoms, 
according to Rome III criteria, with 13.9% presenting with both IBS and GAD (Afridi, Ahmad, 
Sethi, & Irfan, 2017). Additionally, it’s been argued that anxiety disorders have a greater impact 
on the risk, comorbidity, and outcome of IBS than depression (Roy-Byrne et al., 2008).  
Mood disorders are associated with depression and suicide ideation (Van Oudenhove et 
al., 2016). The prevalence of depression was found in 30% of medical-seeking patients 
presenting with FGIDs (Addolorato et al., 2008) with 15% to 38% of clinical patients with IBS 
presenting with suicidal ideation (Miller, Hopkins, & Whorwell, 2004), while anxiety disorders 
were revealed in 30%-50% of clinical patients with FGIDs (Oudenhove, Levy et al., 2016). 
However, depression alone, can alter the number of GI symptoms an individual experience 
including the number of diagnoses made (Bouchoucha et al., 2013; Van Oudenhove et al., 2011). 
Only a few studies have evaluated GI symptoms and depression in an emerging adult population. 
One study with emerging adults found that 13.6% (n=773) of their sample reported moderate to 
major depression (Lisznyai, Vida, Nemeth, & Benczur, 2014).  
The comorbidity of depression and anxiety can be associated with poor health outcomes 
and inferior quality of life (Lackner et al., 2010; Lackner & Gurtman, 2005). Furthermore, 
experiencing chronic GI symptoms can also result in psychological consequences on overall 
health-related quality of life (HQoL)., i.e. “…one’s general well-being, daily function status, and 
sense of control over the symptoms.” (Drossman, 2016, p. 1273). Studies have shown that HQoL 
was significantly lower in individuals with IBS than healthy individuals (Badia et al., 2002). 
Studies concerned with health outcomes in emerging adults were very limited. Nevertheless, one 
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study evaluating HQoL including a population group of 16 to 23-year old participants concluded 
that males reported higher scores than females (Jörngården, Wettergen, & Vo Essen, 2006).  
Albeit promising, research is currently limited on general emerging adult population 
samples. The prevalence of depression is found to be higher in emerging adults than other age 
groups, with 5.8% meeting symptom criteria (Weitzman, 2004). Yet, the presence of depressive 
symptoms in emerging adults, regardless of meeting a clinical diagnostic level, have shown to 
have an effect on health behaviors, including diet (Dalton & Hammen, 2018).  
Biological factors: microbiome, food, & dietary habits. 
The 21st century brought new scientific exploration of the gut microbiota’s enigmatic 
relationship with gut function and brain behavior (Ghoshal & Srivastava, 2014). Gut microbiota 
are the intestinal microbes located within the GI tract that feed on the undigested components of 
foods consumed (Barbara et al., 2016). The gut microbiota ecosystem (microbiome) is an ever-
present part of the bidirectional interaction between the gut-brain axis (Osadchiy, Martin, & 
Mayer, 2019) suggesting a microbiome-gut-brain axis (Oudenhove, et al, 2016). Present research 
has demonstrated the role gut microbiota has in “energy homeostasis, immune function, and the 
development of certain diseases” (Dong & Gupta, 2019, p. 231). Environmental factors including 
stages of early life development, drugs, stress, and diet influence the balance and composition of 
the gut microbiome (Barbara et al., 2016; Evrensel & Ceylan, 2015). Adverse input from these 
factors result in a dysfunctional gut microbiota ecosystem, termed dysbiosis (Sundin, Öhman, 
Simrén, & Magnus, 2017). Researchers studying dysbiosis, frequently encounter the presence of 
anxiety, depression, and IBS, thus concluding that a strong interaction exist between dysbiosis 
and these factors (O’Mahony et al., 2005).  
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Research on the relationship between gut microbiota and FGID have employ advanced 
technological and analytic methods, yet much is still unclear as to the extent of this relationship. 
A recent study employing new machine learning techniques, found that microbial diversity 
decreased as IBS symptom severity increased, distinguishing between mild/moderate, and severe 
levels compared to healthy sample groups, and that these differences were not mediated by diet 
or medications (Tap et al., 2017).  
The gut microbiome is fundamentally established early in life and can remain fairly 
stable even with interference from drugs, infections, and diet, however, studies have shown that 
to some degree, diet can modify both microbiota composition and function in adults (Osadchiy et 
al., 2019, p. 327). Consequently, researchers have begun exploring diet as a potential means to 
create changes in physiological and psychological symptoms via the gut microbiome (Barbara et 
al., 2016; Chey, 2013; Evrensel & Ceylon, 2015). Studies of dietary measurements have 
provided evidence of associations with FGIDs, dysbiosis of the gut microbiome, and 
psychological disorders (Evrensel & Ceylon, 2015; Francisconi et al., 2016). Importantly, the 
relationship between GI symptoms and eating behaviors and diet has been marked as significant 
(Ananthakrishnan et al., 2015; Drossman, 2016; Gibson, Varney, Malakar, & Muir, 2015; Lee et 
al., 2015). 
Assessing dietary intake can be evaluated at the nutrient, food group, and eating pattern 
levels (Jacobs & Steffen, 2003; Lee et al., 2015). Nutrients such as vitamins and minerals, fats, 
fibers, carbohydrates, and proteins, characterize diet at the most basic level (Hu, 2002). At a 
higher level of analysis are food groups. Food groups are defined as grains, vegetables, fruits, 
diary, and protein, as marked by the food pyramid (Marcoe, Juan, Yamini, Carlson, & Britten, 
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2006). At the most macro level of analysis are dietary patterns, such as the Mediterranean or 
Western diet. Dietary patterns are defined as “the quantities, proportions, variety or combination 
of different foods, drinks, and nutrients in diets, and the frequency with which they are habitually 
consumed” (2015 Dietary Guidelines Advisory Committee, 2015, p. 8). “Dietary factors that 
reportedly trigger symptoms include eating patterns as well as specific foods and/or food 
components” (Barbara et al., 2016, p. 1306). 
The Western dietary pattern, also known as the American diet is “characterized by high 
fat, high sugar, high level of red and processed meat, high levels of refined grains and a lower 
level of fiber” (Dong & Gupta, 2019, p. 234). Individuals on the Western diet are at moderate 
risk for developing IBS (Buscail et al., 2017), have low gut microbiota diversity, show higher 
levels of inflammation, and have an increased risk of obesity, colon cancer, and type 2 diabetes 
(Dong & Gupta, 2019; Miyoshi et al., 2017; Schulfer et al., 2018; Turnbaugh et al., 2009). The 
Mediterranean diet, considered the healthiest diet, is “characterized by a beneficial fatty acid 
profile; higher intake of fiber, vegetables, and fruits; and with lower intake of sugar and red 
meat” (Dong & Gupta, 2019, p. 234). Individuals on a Mediterranean diet have rich microbial 
diversity, decreased levels of inflammation and are at lower risk of cardiovascular disease and 
obesity (Ley et al., 2005; Miyoshi et al., 2017; Rivera et al., 2007).  
Evaluating eating habits in an emerging adult population showed that 89% of emerging 
adults were not meeting healthy dietary recommendations, missing serving level requirements 
for all standard food groups (Song, Schuette, Huang, & Hoerr, 1996). The amount of 
carbohydrates consumed exceeded 33% to 46% and they were 53% to 58% of their daily 
vegetable serving requirements (2015-2020 Dietary Guidelines for Americans - Ch2, p42, 2015). 
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Current research on diet and FGIDs indicated mixed results. A study found patients 
diagnosed with FGIDs were more inclined to snack throughout the day, eating fewer meals per 
week than their non-FGID counterparts (Barbara et al., 2016). A large population study 
(n=44,350) in France found the Western dietary pattern connected to a moderate risk for IBS 
(Buscail et al., 2017). Higher levels of constipation were found in Japanese college students who 
frequently skipped breakfast (Fujiwara, 2012) and another study demonstrated the risk of 
ulcerative colitis increased with a high consumption of soft drinks (Nie & Zhao, 2017). Further 
exploring common associations between an individual’s diet and gastrointestinal functioning 
may offer insight into the extent diet plays in the development of FGIDs.  
Conceptual Framework: Defining Patterns of FGID Symptoms in Emerging Adults 
Emerging adulthood is often-overlooked in current GI health research (Park, Mulye, 
Adams, Brindis, & Irwin, 2006). However, as a critical period of development it is important to 
determine the active biopsychosocial factors associated with various GI functioning in emerging 
adults. The purpose of this study was to define common GI symptom subgroups within emerging 
adults and characterize their differences based on key biopsychosocial factors. To accomplish 
this task, the National Institutes of Health (NIH) Patient-Reported Outcomes Measurement 
Information System (PROMIS®) GI symptom scales was administered (Spiegel et al., 2014). The 
PROMIS-GI is currently the only PRO that has been validated to measure symptoms of multiple 
FGID domains in both a general and clinical population group. The use of the NIH PROMIS-GI 
scales afforded this study with a means to measure a broad range of GI functioning and symptom 
levels within a general emerging adult population group. To date, there is no comprehensive 
study exploring general GI functioning in the emerging adult population using the PROMIS-GI 
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symptom scales. To identify underlying GI symptom patterns, a latent class analysis approach 
was employed. Latent class analysis (LCA) is a statistical method that allows the researcher to 
use a set of observed variables to identify hidden but meaningful patterns resulting in a number 
of homogenous subgroups of participants (latent classes) (Schreiber, 2016). The key 
biopsychosocial factors measured included dietary patterns, eating behaviors, mood and anxiety 
disorders, and physical and social functioning related to quality of life. Between class differences 
were established by these variables using a MANOVA. Currently, this is the only study that 
sought to identify underlying GI patterns and associated psychosocial factors within a general 
emerging adult population group.  
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Method 
Participants 
Undergraduates enrolled in introductory psychology courses at a large university in the 
south-eastern United States were recruited to participate in this study for course credit. 
Introductory psychology is a required course for all programs at this university. Eligibility 
criteria excluded vulnerable populations and required participants to be between the age of 18 
and 25 years and able to complete an online questionnaire in the English language. All measures 
were administered online. This study was approved by the Institutional Review Board. 
Measures 
The online survey included 198 questions assessing the following: FGID symptoms, 
dietary patterns, eating behaviors, depression and anxiety symptoms and emotional and physical 
functioning. In addition, the survey included demographic items such as age, gender, 
race/ethnicity, education, income, and living arrangements. The survey took approximately 30 
minutes to complete. Nine validity check questions were also included in the questionnaire as a 
determining variable for respondent data retention or elimination. The data analysis for this paper 
was generated using Qualtrics software (Qualtrics, Provo, UT). 
Functional gastrointestinal assessment. 
The NIH PROMIS-GI symptom scales. The National Institutes of Health (NIH) Patient-
Reported Outcomes Measurement Information System (PROMIS®) Gastrointestinal Symptom 
Scales (PROMIS-GI) were developed in 2014. The PROMIS-GI scales are disease-agnostic, thus 
allowing for the characterization of a broad range of GI symptoms within the general population 
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(Shah, Almario, Speigel, & Chey, 2018; Spiegel et al., 2014). These scales have been employed 
in several GI studies validating its ability to measure GI symptom burden and to characterize GI 
symptom differences (Shah et al., 2018). Importantly, the PROMIS-GI symptom scales may be 
effective in identifying clinical thresholds for action (Spiegel et al., 2014). The PROMIS-GI 
scales were developed using multiple patient focus groups and an extensive systematic literary 
review. A psychometric evaluation confirmed the internal construct validity of the PROMIS-GI 
Scales (Spiegel et al., 2014). The PROMIS-GI has been validated in studies as an effective PRO 
measure to be used in both clinical and general populations (Spiegel et al., 2014). The PROMIS-
GI scales evaluate eight GI symptom domains, of which this study focused on six: abdominal 
pain (6 items), gas/bloating (12 items), diarrhea (5 items), constipation (9 items), 
gastroesophageal reflux (GER) (13 items), and nausea/vomiting (4 items).  Individuals’ scores 
were provided as a T-score metric with 50 representing the U.S. general population mean with a 
standard deviation (s.d.) of 10 (Spiegel, et al, 2014). The higher the T-score, the greater the 
severity of the symptom. Scores were calculated by pre-determined algorithms available via the 
PROMIS website. T-scores were then converted into GI symptom severity levels using the 
suggested general PROMIS T-Score threshold range of mild (t-scores between 55 and 60), 
moderate (t-scores between 60 and 70), and severe (t-scores above 80).   
Dietary assessments. 
14-Item Mediterranean Diet Adherence Screener (MEDAS). The dietary behaviors 
were evaluated in this study due to their confirmed validity in association with FGIDs 
(Ananthakrishnan, 2015; Barbara et al., 2016; Chey, 2013; Drossman, 2016; Evrensel & Ceylon, 
2015; Francisconi et al., 2016; Gibson, et al., 2015; Lee, 2015). Assessing dietary patterns is one 
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of the preferred methods used in research (Hu, 2002) as they describe eating behaviors generally 
consistent over time (Quatromoni et al., 2002). The Mediterranean Diet (MedDiet) is a 
frequently recommended dietary pattern by nutritional research and the USDA (Scientific Report 
of the 2015 Dietary Guidelines Advisory Committee, Part D. Chapter 2). This study employed 
the validated 14-Item (MEDAS) to assess individuals’ degree of adherence to the MedDiet. The 
14-Item MEDAS is the English version of the original Spanish version, PREvencion con 
DIetaMEDiterranea (PREDIMED) (Papadaki et al., 2018). It is scored (0-14) based on 14 
questions (Martínez-González et al., 2012). This questionnaire has been validated in Spain and 
the UK for its objective assessment of adherence to the MedDiet (Martínez-González et al., 
2012; Papadaki et al., 2018). The main outcome measure was the level of adherence to the 
Mediterranean diet.  
Psychosocial assessments.  
Past research has confirmed that anxiety, depression and HQoL is associated with many 
FGID symptoms and their level of severity (Addolorato et al., 2008; Badia et al., 2002; Lisznyai 
et al., 2014; Miller et al., 2004; Oudenhove et al., 2016; Roy-Byrne et al., 2008). Specifically, 
relevant to evaluating FGIDs, the Rome IV committee provided within their supplementary 
materials their recommended measures for assessing psychosocial factors associated with FGIDs 
(Oudenhove et al., 2016). These include the GAD-7, PHQ-9 and SF-36.   
Generalized Anxiety Disorder Screener (GAD-7). This study evaluated generalized 
anxiety disorder (GAD) using the Generalized Anxiety Disorder Screener (GAD-7) instrument, 
which recorded the level of general anxiety experienced within the past two weeks using a set of 
7 questions (Spitzer, Kroenke, Williams, & Lowe, 2006). The GAD-7 scored each question from 
 22 
0 (not at all) to 3 (nearly every day) with a total score of 21. Summary scores of 5, 10, and 15 
were used as threshold values for mild, moderate and severe anxiety (Spitzer et al., 2006). The 
GAD-7 was constructed using existing GAD criteria from the Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition (DSM-IV) (Spitzer et al., 2006). It has been validated by 
multiple studies (Löwe et al., 2008). 
Patient Health Questionnaire (PHQ-9). The Rome IV committee recommends screening 
for suicide ideation when depression is severe and accompanied with feelings of hopelessness 
and severe/persistent abdominal pain (Oudenhove et al., 2016). To evaluate depressive 
symptoms, the Patient Health Questionnaire (PHQ-9) was administered. In keeping to the 
diagnostic criteria of the DMS-IV, the PHQ-9 measures the level of depression, including suicide 
ideation (Kroenke, Spitzer, & Williams, 2001). This instrument consists of 9 items, scored 0 (not 
at all) to 3 (nearly every day), with a total summary score of 27. The severity of depression can 
be calculated using validated cut-off points with scores above 10 qualifying as a form of 
depression, and scores of 15 or greater indicating major depression (Kroenke et al., 2001). The 
PHQ-9 is a simplified version of the 3-page Patient Health Questionnaire used by clinicians to 
diagnose their patients for depression. The PHQ-9 has been validated and replicated by mental 
health professionals conducting patient interviews and comparing the PHQ-9 with current 
measurement tools in place (Kroenke et al., 2001).  
RAND 36-Item Health Survey 1.0 (SF-36). Studies have concluded that GI symptoms 
correlate negatively with HQoL (Halder et al., 2003). This study employed the RAND 36-Item 
Health Survey 1.0 (SF-36) measuring eight separate domains along with two summary scores on 
mental and physical health (Hays, Sherbourne, & Hazel, 1993). A mental summary score was 
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calculated using the four domains: emotional wellbeing, social functioning, energy/fatigue, and 
role limitations due to emotional problems. The physical health summary score was derived from 
the remaining four domains: physical functioning, pain, role limitations based on physical health, 
and general health perception (Cunningham, Nakozono, Tsai, & Hays, 2003). Of note, the 
version of the SF-36 used in this study was based on the RAND-36 scoring algorithms rather 
than the original SF-36 scoring method. The key difference is that the RAND-36 summary 
scores were calculated based on the assumption that physical and mental health is correlated 
(Cunningham et al., 2003). The original SF-36 was constructed in 1992 during the Medical 
Outcome Study from longer patient-completed forms (Ware & Sherbourne, 1992). The RAND-
36 uses the exact same items as the SF-36 (Cunningham et al., 2003). It has been validated in 
numerous studies for accurately measuring health-related quality of life (Oudenhove et al., 
2016). 
Demographic assessments.  
Demographic information collected in this study can be grouped by: (i) general standard 
items (age, gender, race/ethnicity, marital status); (ii) socioeconomic (ii) birth profile (birth 
mode, breastfed); (iii) current housing; (iv) and physiological profile (BMI, allergies, taking 
antibiotics, probiotics, or multivitamins). See Table A1 for detailed list of question items.  
Statistical Analysis  
Data from the PROMIS-GI symptoms scales were analyzed in LatGold v5.1.0.18311 
(Statistical Innovations Inc.), a latent class analysis software package. LCA methods have the 
same goal as traditional cluster analysis, in that both attempt to create the largest between-cluster 
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and smallest within-cluster differences. However, unlike standard cluster methods, LCA uses a 
probabilistic model-based approach rather than distance measures of dissimilarity (Kent, Jensen, 
& Kongstad, 2014). Additional advantages for using the LCA includes: (i) greater control of the 
criteria used to determine clusters, (ii) normal distribution of variables are not required, and (iii) 
mixed measurement levels can exist between variables in the same test (Schreiber, 2016; 
Vermunt & Magidson, 2002). The ideal model was based on appropriate model fit, the number 
of individuals per class, the certainty of being assigned to one class (membership probability), 
and significant difference between classes (Kongsted & Nielsen, 2017).  
Class differences based on biopsychosocial factors were then explored using multivariate 
analysis of variance (MANOVA) analysis. Subgroups that differed significantly were compared 
at a pair level using the least significant difference (LSD) test. A p value of < 0.05 was 
considered statistically significant. Both MANOVA and LSD tests were conducted in SPSS 
(IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM 
Corp.).   
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Results 
The final study sample totaled 956 emerging adults between the age range of 18 and 25 
(M=18.97, SD = 1.47) with 58.3% identifying as female, and 57.3% identified as Caucasian. To 
evaluate the presence of GI symptoms within the emerging adult sample group, the T-scores 
derived from the PROMIS-GI symptoms scales were assigned a rating of 1 through 4, as 
illustrated in Figure 2, marking symptom severity.  
Figure 2 PROMIS Symptom Severity Range  
 
Note. Symptom severity ratings were based on the recommended PROMIS T-Score ranges, using the mean of 50 and standard 
deviation (SD) of 10. Normal limits (1) = t-scores < 55; Mild (2) = t-scores between 55 – 60; Moderate (3) = t-scores between 
60 – 70; Severe (4) = t-scores > 70. Adapted from http://www.healthmeasures.net/score-and-interpret/interpret-scores/promis  
 
Symptom prevalence was assessed using the severity scores. As presented in Table 3, 
25.8% of the emerging adult sample group did present at least one GI symptom.   
Table 3 Overall GI Symptom Severity Found in Participants (n=956) 
GI Symptom Severity  Belly Pain Constipation Diarrhea  Gas/ 
Bloating  
Nausea/ 
Vomiting 
Reflux/ 
Heartburn 
Within Normal Limits (1) 750 (78.5%) 845 (88.4%) 870 (91%) 608 (63.6%) 699 (73.1%) 891 (93.2%) 
Mild (2) 99 (10.4%) 77 (8.1%) 53 (5.5%) 247 (25.8%) 142 (14.9%) 49 (5.1%) 
Moderate (3) 91 (9.5%) 34 (3.6%) 32 (3.3%) 99 (10.4%) 105 (11%) 15 (1.6%) 
Severe (4) 16 (1.7%) - 1 (0.1%) 2 (0.2%) 10 (1%) 1 (0.1%) 
Note. Levels of severity were interpreted using the threshold range guidelines developed by the NIH to be used with their 
PROMIS measures. Within Normal Limits = T-scores < 55; Mild = T-Scores between 55 and 60; Moderate = T-Scores between 
60 and 70; Severe = T-scores > 70. There was no endorsement for severe constipation within the sample group.  
 
Having confirmed the presence of GI symptoms in this emerging adult sample group, 
latent class analysis (LCA) was explored using the assigned symptom severity scores 1-4.  
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A baseline model was created using a 1-Class (latent) cluster model (Myrseth & 
Notelaers, 2018). Classes were subsequently added and compared to the baseline 1-Class model.  
Model sizes with up to 7 classes were calculated as there were no previous studies that suggested 
the number of classes for conducting a latent class analysis using the PROMIS-GI scales. Each 
estimation model was replicated 10 times to determine the most frequently occurring Bayesian 
Information Criterion results per model (Nielsen, Vach, Kent, & Kongsted, 2016). By selecting 
the most common solution, the evaluations will be using the most likely scenario.  
Model Selection 
Table 4 provides an overview of the various information criteria considered in 
determining the best model fit. The information criteria consisted of the likelihood ratio chi-
squared statistic (L2) and Bayes Information Criterion (BIC) with lower values indicating 
improved model prediction of the data (Vermunt & Magidson, 2016, p.69). The L2 statistic 
calculates the similarity between model-based estimated frequencies and observed frequencies 
with smaller values indicating better model fit. The BIC accounts for model complexity and 
endorses model parsimony of the latent classes, and when using sample sizes larger than 500, 
proves to be a superior indicator to model fit compared to all other information criteria (Nylund, 
Asparouhov, & Muthen, 2007, p. 563). A more formal assessment of the model holding true for 
the population is determined by the p-value with p < 0.05 indicating a poor model fit. Due to 
some of the GI symptom severity levels containing small group sizes, a bootstrapping method 
was used to better assess the global fit of the model (Nylund et al., 2007).  Additionally, entropy 
R-squared was evaluated for quality of membership classification with values closest to 1 
indicating improved probability of an individual belonging to just one class (Schreiber, 2016). 
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Individual class sizes below 3% were considered to be too small for this study. Accordingly, the 
class sizes in the 4-Class model and higher did not meet the minimum distribution requirement 
and was thus eliminated. Of note, the 3-Class model indicated a small sample group (n=50) for 
their 3rd class which would be acceptable if the cluster/class was describing an element that is 
uncommon in the sampled emerging adults.  
The 2-Class model had the lowest BIC, however, both the L2 and p-value were not ideal. 
Additionally, according to the conditional bootstrap analysis, the 3-Class model showed a 
statistically significant improvement over the 2-Class model (p < 0.05, 0.00 s.e.) for overall 
model fit, thus the 3-Class model was selected.  
Table 4 Summary of Statistical Model Fit Statistics Used for Model Selection 
Model BIC L2 df pa Entropy Class. Err. 
Baseline 1-Class Model 6798.2738 1185.6210 940 1.00 1.00 0.0000 
2-Class Model 6339.2847 603.0833 922 0.0020 0.7033 0.0621 
3-Class Model 6344.9257 485.1760 904 0.0980 0.6426 0.1101 
4-Class Model 6426.8327 443.5345 886 0.0640 0.6548 0.1139 
5-Class Model 6518.9844 412.1377 868 0.0119 0.6022 0.1637 
6-Class Model 6624.2116 393.8164 850 0.0142 0.6939 0.1347 
7-Class Model 6722.1687 368.2251 832 0.0103 0.7045 0.1332 
Note. Comparison between the 2-Class and 3-Class are shown with values in bold indicating optimal values. The 4-Class and 
higher models did not meet the minimum group size criteria. BI = Bayesian information criterion; L2 = Likelihood-ratio; df = 
degrees of freedom; p = p-value; Entropy = quality of predicting model classification with values closer to 1 preferred; Class. 
Err. = classification errors.  
a p value calculated using bootstrap method. 
 
 
Describing the Latent Classes 
Between-class differences were described based on the high conditional probabilities 
(values > 0.5) for class assignment, available in Table A2. Additionally, differences between 
classes are graphically illustrated in Figure 2 based on the T-Score means for each class. The 
differences between these classes are statistically significant (p < .001) for each symptom 
domain, as shown in Table A3. It was concluded that the 3-Class model adequately identified 
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three unique latent classes that were informative to the study and could be defined based on their 
GI symptom patterns. The three classes were described as Normal (649 individuals, 64.15%), 
Mild (257 individuals, 30.30%), and Moderate (50 individuals, 5.55%). Symptom severity 
marked the main difference between these classes. The differences between the Mild, and 
Moderate groups was found in the increased symptom severity of belly pain, gas/bloating, and 
nausea/vomiting with the Moderate class also endorsing moderate constipation along with mild 
diarrhea and reflux/heartburn. A comparison of the demographic information among the three 
latent classes are provided in Table A5. 
Figure 3 3-Class Model Profile Plot Using Conditional Mean T-Scores per Class   
 
 
 
Note. PROMIS T-Score ranges for GI symptoms include Normal limits = < 55; Mild = between 55 – 60; Moderate = between 
60 – 70; Severe = > 70. 
 
Comparisons of Biopsychosocial Factors  
Based on previous literature, this study hypothesized that the three latent classes will 
differ on biopsychosocial factors with a decrease in psychosocial functioning as levels of GI 
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symptoms increase (Mild and Moderate classes). Demographic analyses revealed differences 
between the three groups in the proportion of men and women (χ2(2) = 75.431, p < .001) with 
females dominating both the Mild and Moderate groups (Normal = 48.8%, Mild = 77.1%, 
Moderate = 84%). Therefore, it was also hypothesized that the scores for biopsychosocial factors 
for each of the GI groups would depend on sex. A two-way MANOVA was run with two 
independent variables – sex and GI symptom groups – and five dependent variables - 
Mediterranean diet (MEDAS) score, anxiety (GAD-7) score, depression (PHQ-9) score, and the 
overall emotional (SF-36 MH) and physical functioning (SF-36 PF) scores. The combined 
dependent variables were used to assess biopsychosocial functioning.  
Evidence of multicollinearity was found, as assessed by Pearson correlation (|r| > 0.9) 
between the SF-36 MH and PHQ-9, therefore, the mental health summary score for the SF-36 
was removed. Univariate outliers were present in the data (n=25), as assessed by inspection of a 
boxplot, and multivariate outliers (n=25), as assessed by Mahalanobis distance (p < .001). 
Outliers were retained because analysis with and without these cases proved to have a 
statistically trivial effect. The interaction effect between sex and GI symptom groups on the 
combined dependent variables was statistically significant, F(8, 1896) = 2.638, p = .007, Pillai’s 
V = .022, partial η2 = .011. Follow up univariate two-way ANOVAs were run for each dependent 
variable.  
Analysis showed a statistically significant interaction effect between sex and GI group for 
physical functioning scores, F(2, 950) = 8.301, p < .001, partial η2 = .017, but not for the 
Mediterranean diet score, F(2, 950) = 10.677, p = .069, partial η2 = .006, depression, F(2, 950) = 
1.561, p = .210, partial η2 = .003, or anxiety, F(2, 950) = 1.388, p = .250, partial η2 = .003. As 
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such, a simple main effects analysis for physical functioning was conducted. A statistical 
difference was observed between GI groups and males for physical functioning, F(2, 950) = 
36.837, p < .001, partial η2 = .072, and for females, F(2, 950) = 27.026, p < .001, partial η2 = 
.054. Table A6 shows simple comparisons for differences in mean physical functioning scores 
between GI groups for males and females demonstrating a statistically significant difference 
between all three GI groups for both males and females. Thus, it could be concluded that GI 
symptom groups and physical functioning scores vary by sex. However, the main interaction 
effect between GI groups and sex was considered trivial due to the small effect size (partial η2 = 
.011), warranting a separate evaluation of the main effects for GI groups and sex on 
biopsychosocial factors. 
There was a statistically significant main effect of GI symptom groups on the combined 
dependent variables, F(8, 1896) = 23.322, p < .001, Pillai’s V = .179, partial η2 = .090. Follow 
up univariate two-way ANOVAs were run, showing a statistically significant main effect of GI 
groups on physical functioning, F(2, 950) = 61.194, p < .001, partial η2 = .114, depression, F(2, 
950) = 47.924, p < .001, partial η2 = .092, anxiety, F(2, 950) = 54.438, p < .001, partial η2 = 
.103, but not for the Mediterranean diet, F(2, 950) = 1.922, p =.147, partial η2 = .004. 
Additionally, there was a statistically significant main effect of sex on the combined dependent 
variables, F(4, 947) = 5.95, p < .001, Pillai’s V = .025, partial η2 = .025. Follow up univariate 
two-way ANOVAs were run showing a statistically significant main effect of sex for the 
Mediterranean diet, F(1, 950) = 16.794, p < .001, partial η2 = .017, and physical functioning, 
F(1, 950) = 6.707, p = .010, partial η2 = .007, but not for anxiety, F(1, 950) = .873, p = .350, 
partial η2 = .001, or depression, F(1, 950) = .017, p = .897, partial η2 = < .001.  
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As such, a post hoc Tukey pairwise comparison was conducted to evaluate the 
differences in mean biopsychosocial scores between GI symptom groups and also between sex. 
Table 6 summarizes the comparison for GI symptom groups and Table 7 the sex differences.  
Table 6 Differences Between Biopsychosocial Factors and GI Symptom Classes  
 Latent classification GI group 
Mean (SD) or N [%]   
MANOVA  
main effect   
Post hoc tests 
Mean difference significance 
Variables Normal (n=648) 
Mild 
(n=258) 
Moderate 
 (n=50)  F p η
2  
Normal 
(v) 
Mild 
Normal 
(v) 
Moderate 
Mild  
(v) 
Moderate 
Biological             
   Med diet1 5.36  
(2.05) 
5.80  
(1.93) 
5.50  
(1.84) 
 1.922 .147 .004  ** ns ns 
Psychosocial             
   GAD-7 3.95  
(4.43) 
7.57 
(5.58) 
10.60 
(6.45) 
 54.438 < 0.001 .103  *** *** *** 
   SF-36 (PF) 85.24  
(10.85) 
78.12 
(13.69) 
68.91 
(18.37) 
 61.194 < 0.001 .092  *** *** *** 
   PHQ-9 4.90  
(4.57) 
8.47  
(5.63) 
10.30  
(6.525) 
 47.924 < 0.001 .092  *** *** * 
Note. post-hoc comparisons were evaluated using Tukey HSD and are marked according to the degree of significant difference. 
ns = non-significant. The mean difference was significant at the .05 level. GAD-7= Generalized Anxiety Disorder; SF-36 (PF) 
Social functioning summary score for physical functioning; PHQ-9 = Patient health questionnaire to evaluate depression;  
1Mediterranean dietary adherence score;  
⁎ p < .05. ⁎⁎ p < .01. ⁎⁎⁎ p < .001. 
 
Table 7 Differences Between Biopsychosocial Factors and Sex 
  
Male  Female  MANOVA main effect for sex on Biopsychosocial Factors  
Post hoc tests  
Mean difference 
significance 
Variables  N Mean (SD)  N Mean (SD)  F p η2  Male (v) Female 
Med diet             
   Normal GI  332 5.13 (2.07)  316 5.59 (2.01)  8.779 .003 .009  ** 
   Mild GI  59 5.12 (2.00)  199 6.00 (1.87)  8.886 .003 .009  ** 
   Moderate GI  8 3.75 (1.39)  42 5.83 (1.84)  7.397 .007 .008  ** 
GAD-7             
   Normal GI  332 3.07 (3.68)  316 4.88 (4.93)  22.815 .000 .023  *** 
   Mild GI  59 6.56 (5.23)  199 7.86 (5.65)  3.332 .068 .003  ns 
   Moderate GI  8 11.63 (5.66)  42 10.40 (6.63)  .430 .512 .000  ns 
SF-36 (PF)             
   Normal GI  332 86.62 (9.44)  316 83.78 (12.00)  8.996 .003 .009  ** 
   Mild GI  59 77.8 (13.62)  199 78.22 (13.75)  .056 .813 .000  ns 
   Moderate GI  8 55.85 (22.24)  42 71.4 (16.72)  11.185 .001 .012  ** 
PHQ-9             
   Normal GI  332 4.23 (4.13)  316 5.60 (4.90)  12.248 .000 .013  *** 
   Mild GI  59 8.10 (4.79)  199 8.58 (5.87)  .427 .514 .000  ns 
   Moderate GI  8 11.63 (5.48)  42 10.05 (6.74)  .678 .411 .001  ns 
Note. post-hoc comparisons were evaluated using Tukey HSD and are marked according to the degree of significant 
difference. ns = non-significant. The mean difference was significant at the .05 level. GAD-7= Generalized Anxiety 
Disorder; SF-36 (PF) Social functioning summary score for physical functioning; PHQ-9 = Patient health questionnaire to 
evaluate depression;  
1Mediterranean dietary adherence score;  
⁎ p < .05. ⁎⁎ p < .01. ⁎⁎⁎ p < .001. 
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Discussion 
 Research on GI health has generally focused on adults who seek out medical treatment 
for their GI symptoms. Indeed, the recent literature has demonstrated that GI symptoms are 
common in the general population, however, there is very limited information on GI symptoms 
and associated factors in emerging adults, those between the ages of 18 and 25. Identifying 
patterns of GI symptoms in emerging adults along with associated biopsychosocial factors may 
provide valuable information about the etiology of FGIDs and suggest the most effective 
treatment strategies for these symptoms. Therefore, this study assessed both GI symptoms and 
key biopsychosocial variables in a group of 956 emerging adults to determine if meaningful 
patterns would emerge. Furthermore, this is the first study to evaluate a range of GI symptoms 
within an emerging adult population using PROMIS-GI measures. Latent class analyses revealed 
that 30% of the emerging adults surveyed experienced one or more GI symptom, with 5.5% of 
the sample reaching levels of GI symptom severity associated with clinical diagnoses. Three 
latent GI classes were identified, Normal (n=649, 64.15%), Mild (n=257, 30.30%), and Moderate 
(n=49, 5.55%). GI symptom severity marked the main difference between these classes. 
Additionally, differences were observed between men and women. The Mild and Moderate 
groups were predominantly female. 
Previous general U.S. population studies have indicated that between 35% and 69% of 
the general population presents with at least one GI symptom (Almario et al., 2018; Camilleri et 
al., 2005; Drossman et al, 1993). That rate is higher than the 30% that was obtained here in a 
sample of emerging adults. Breaking down the data into specific GI symptom domains also 
reveals differences across studies. For example, lower levels of heartburn/reflux and higher 
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levels of gas/bloating were obtained in the current study as compared to the National GI Survey 
in 2015 (Almario et al., 2018).  
Studies on GI symptoms in emerging adults are limited, however one indicated 51.2% of 
Canadian-based university students endorsed at least one GI symptom (Norton et al., 1999) and 
in another 65% of Korean-based nursing students reported more than one GI symptom (Lee et 
al., 2011). The high incidence of GI symptoms in emerging adults given that this age range 
should be of optimal health is surprising. One commonality between these studies is that all used 
convenience samples of emerging adults that were college or professional students. Student 
populations are under high stress (D’Zurilla & Sheedy, 1991) and these findings may reflect a 
relationship between GI functioning and stress among the other factors described above.  
A review of the literature indicates that GI symptoms are frequently associated with 
anxiety and depression (Addolorato et al., 2008; Badia et al., 2002; Lisznyai et al., 2014; Miller 
et al., 2004; Van Oudenhove et al., 2016; Roy-Byrne et al., 2008). For example, previous studies 
showed 13.9% of their sample presenting with both IBS and anxiety (Afridi et al., 2017) and 
another found depression in 30% of medical-seeking patients presenting with FGIDs 
(Addolorato et al., 2008). In the current study, the Moderate GI symptom group met the GAD-7 
threshold for moderate anxiety levels and the Moderate GI symptom group also met the PHQ-9 
threshold score of 10 or higher for moderate or severe depression. 
The gut-brain axis is the proposed communication pathway for psychosocial and GI 
functioning to interact. The GI symptoms and associated psychosocial measures found in this 
study are consistent with the existence of a gut-brain axis communication pathway. The bi-
directional communication between the gut and brain is integral in maintaining homeostasis and 
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an imbalance in either can have adverse consequences (Foster, Rinaman, & Cryan, 2017). 
Following this theory, psychosocial functioning can excite or suppress the GI system, or GI 
functioning can excite or suppress psychosocial functioning (Van Oudenhove et al., 2016). This 
study observed that mood, anxiety, and GI symptom severity were strongly correlated and 
therefore clearly interacting. 
Diet was examined in relation to GI symptom groups and the results were not in the 
direction that was expected. Generally psychosocial functioning was predicted to decrease as GI 
symptom severity increased and diet was considered one aspect of psychosocial functioning. 
Results suggest that the Mild GI symptom group actually exhibited higher levels of adherence to 
the Mediterranean diet than either the Normal GI symptom group or the Moderate GI symptom 
group. This finding may reveal an early response by individuals to eat a healthy diet in response 
to GI symptoms. Alternatively, the particular diet examined here; the Mediterranean Diet is high 
in legumes and vegetables. This diet may lead to higher levels of gas and bloating and may result 
in mild GI symptoms. 
Additionally, evidence of the regulation of the gut-brain axis via microbiota was 
discussed, including how diet may influence this relationship. Although diet did present as a 
differentiating factor between the three subgroups, it was not associated with GI health and its 
effect was very small. It could be suggested that adherence to a healthy diet at this stage in life 
may be limited in keeping the gut-brain axis in balance. The composition of the microbiota is 
fundamentally established during childhood (Foster et al., 2017) and therefore, diets intended to 
alter the microbiota may need to be more targeted and aggressive to achieve meaningful results.  
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Limitations. The emerging adult population used here was drawn from a university 
sample, thus generalizing results to the population of emerging adults remains to be determined. 
However, it should be noted that the sample drawn were from a general psychology class, 
required by all students, regardless of their major. This study was a cross-sectional study and 
thus causation could not be determined. When GI and psychosocial symptoms emerged in 
relation to one another could not be determined. Two PROMIS-GI scales were excluded from 
the survey measures; one focused on disrupted swallowing and the other on bowel incontinence. 
Furthermore, evidence suggest that GI symptom severity increase during menstruation 
(Bernstein et al., 2014), however, this study did not account for this possible interaction between 
menses and belly pain.  
Future directions. This study demonstrated that over a third of emerging adults 
attending college are experiencing at least one GI symptom and that these symptoms form 
unique patterns, distinguishable by levels of severity in GI symptoms. Anxiety and depression 
varied by severity of GI symptoms. Including all PROMIS-GI measures in future research would 
provide a broader scope of GI functioning. Furthermore, additional insight will be gained by 
comparing the GI symptom groups on other demographic and psychosocial measures. Future 
studies should consider measuring GI and psychosocial variables over repeated intervals with a 
time-series design. That way possible cause and effect relationships may be determined. Future 
research evaluating GI symptoms in emerging adults should include healthcare seeking measures 
to determine the likelihood that this population accesses medical support. Based on this study’s 
findings, it is recommended that university health service providers evaluate patterns of GI 
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health when students present with anxiety and depression, and conversely they should assess 
anxiety and depression when students present with GI complaints.  
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Appendix 
Abbreviations Definitions 
CVD Cardiovascular disease 
FGID Functional Gastrointestinal Disorder 
GER Gastroesophageal Reflux 
GI Gastrointestinal 
HQoL Health-related quality of life 
IBS Irritable Bowel Syndrome 
LCA Latent Class Analysis 
NIH National Institute of Health 
PRO Patient-Reported Outcome 
PROMIS Patient-Reported Outcomes Measurement Information System 
RAP Recurrent abdominal pain 
MedDiet Mediterranean Diet 
PREDIMED PREvencion con DIetaMEDiterranea 
MEDAS Mediterranean Diet Adherence Screener 
STC Starting the Conversation  
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A1 Descriptive Characteristics of Participants  
Variable n % 
Age   
   18 515 53.9% 
   19 222 23.2% 
   20 94 9.8% 
   21 52 5.4% 
   22 33 3.5% 
   23 19 2.0% 
   24 10 1.0% 
   25 11 1.2% 
Sex   
   Male 399 41.7% 
   Female 557 58.3% 
Race/ethnicity   
   Non-Hispanic white 548 57.3% 
   Non-Hispanic black 114 11.9% 
   Puerto Rican 51 5.3% 
   Mexican-American 14 1.5% 
   Other Hispanic 108 11.3% 
   Asians 92 9.6% 
   American Indian 10 1.0% 
   Other 19 2.0% 
   Identified with 2+ ethnicities  81 8.5% 
Living Arrangements   
   On campus 474 49.6% 
   Off campus 482 50.4% 
Total Household Income   
   0-50,000 362 37.9% 
   50,001-100,000 295 30.9% 
   100,001-150,000 166 17.4% 
   ≥ 150,001 133 13.9% 
Health   
   Allergies 300 31.4% 
   Currently taking antibiotics 48 5.0% 
   Taking antibiotics past 2 months 197 20.6% 
   Taking probiotics 89 9.3% 
   Taking multivitamins 356 37.2% 
   Currently a smoker 130 13.6% 
Body Mass Index (BMI)   
   Underweight ≤ 18.5 47 7.9% 
   Normal weight = 18.5 – 24.9 629 65.8% 
   Overweight = 25 – 29.9 168 17.6% 
   Obesity = BMI of 30 or greater 112 11.7% 
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A2 Class Membership Probabilities of the 3-Class Model 
 Distribution of the three GI latent classes 
 Normal Mild Moderate 
PROMIS-GI Symptom Indicators 64.15% 30.30% 5.55% 
Belly Pain 
   
   Within Normal Limits 0.7992 0.1864 0.0144 
   Mild 0.1213 0.8392 0.0394 
   Moderate 0.0149 0.6836 0.3015 
   Severe 0.0349 0.2848 0.6802 
Constipation 
   
   Within Normal Limits 0.7013 0.2897 0.0090 
   Mild 0.1874 0.5434 0.2691 
   Moderate 0.1852 0.0874 0.7274 
   Severe    
Diarrhea 
   
   Within Normal Limits 0.6994 0.2726 0.0280 
   Mild 0.0717 0.7942 0.1342 
   Moderate 0.0321 0.3254 0.6425 
   Severe 0 0 1.0000 
Gas / Bloating 
   
   Within Normal Limits 0.8377 0.1543 0.0081 
   Mild 0.3973 0.5677 0.0350 
   Moderate 0.0587 0.5626 0.3788 
   Severe 0 0 1.0000 
Nausea / Vomiting 
   
   Within Normal Limits 0.7843 0.2050 0.0107 
   Mild 0.2777 0.6172 0.1051 
   Moderate 0.2249 0.5381 0.2370 
   Severe 0.1953 0.2248 0.5799 
Reflux / Heartburn 
   
   Within Normal Limits 0.6793 0.2888 0.0319 
   Mild 0.1347 0.6011 0.2642 
   Moderate 0.0968 0.1918 0.7114 
   Severe 0 0 1.0000 
Note. Items in bold indicate high conditional probabilities that characterize each class. Percent values represent the class size 
based on the overall sample population.   
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A3 Paired Comparisons Between Classes Within the 3-Class Model 
Models for Indicators   p-value  Models for Indicators   p-value 
Belly Pain     Constipation    
   Class  1 2 5.1e-6     Class  1 2 0.00017 
   Class  1 3 0.00040     Class  1 3 5.8e-14 
   Class 2 3 3.5e-5     Class 2 3 3.5e-6 
Diarrhea     Gas / Bloating    
   Class  1 2 0.0031     Class  1 2 6.8e-15 
   Class  1 3 7.9e-5     Class  1 3 1.1e-7 
   Class 2 3 6.3e-6     Class 2 3 2.6e-6 
Nausea / Vomiting     Reflux / Heartburn    
   Class  1 2 7.4e-15     Class  1 2 0.0011 
   Class  1 3 1.5e-14     Class  1 3 2.6e-10 
   Class 2 3 0.00011     Class 2 3 0.00053 
Note. P-values reveal that all latent classes are statistically significantly different between the groups for GI symptoms.  
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A5 Descriptive Statistics of the Classes within the 3-Class model  
 
Normal1 
(n=647) 
Mild2 
(n=257) 
Moderate3 
(n=49) 
Age (years)    
   Mean 18.94 (SD = 1.437) 19.03 (SD = 1.536) 19.08 (SD = 1.592) 
Gender    
   Male 332 (51.2%) 59 (22.9%) 8 (16%) 
   Female 316 (48.8%) 199 (77.1%) 42 (84%) 
Race/ethnicity    
   Non-Hispanic whites 360 (55.6%) 157 (60.9%) 31 (62%) 
   Non-Hispanic blacks 96 (14.8%) 13 (5%) 5 (10%) 
   Latinos 111 (17.1%) 53 (20.5%) 14 (28%) 
   Asians 63 (9.7%) 27 (10.5%) 2 (4%) 
   Other 18 (2.8%) 8 (3.1%) 3 (6%) 
   Identified with 2+ ethnicities    
   Foreign born persons    
Living Arrangements    
   On campus 330 (50.93%) 121 (46.90%) 23 (46%) 
   Off campus 318 (49.07%) 137 (53.10%) 27 (54%) 
Total Household Income    
   0-50,000 245 (37.8%) 100 (38.76%) 17 (34%) 
   50,001-100,000 200 (30.86%) 110 (42.64%) 15 (30%) 
   100,001-150,000 119 (18.36%) 39 (15.12%) 8 (16%) 
   ≥ 150,001 84 (12.96%) 39 (15.12%) 10 (20%) 
Health    
   Allergies 185 (28.5%) 92 (35.7%) 20 (40%) 
   Currently taking antibiotics 25 (3.9%) 16 (6.2%) 7 (14%) 
   Taking probiotics 52 (8%) 28 (10.9%) 9 (18%) 
   Taking multivitamins 227 (35%) 102 (39.5%) 27 (54%) 
   Currently a smoker 81 (12.5%) 41 (15.9%) 8 (16%) 
Body Mass Index (BMI)    
   Underweight ≤ 18.5 52 (8.02%) 20 (7.75%) 4 (8%) 
   Normal weight = 18.5 – 24.9 424 (65.43%) 171 (66.28%) 34 (68%) 
   Overweight = 25 – 29.9 115 (17.75%) 35 (13.57%) 9 (18%) 
   Obesity = BMI of 30 or greater 57 (8.8%) 23 (8.91%) 3 (6%) 
Note. Percent values indicate the percent within the subgroup. 
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A6 Simple Comparisons for Physical Functioning Differences According to GI Group and Sex Interaction 
 Latent classification GI group  MANOVA  main effect   
Post hoc tests 
mean difference significance 
Sex Normal Mild Moderate  F p η2  
Normal 
(v) 
Mild 
Normal 
(v) 
Moderate 
Mild  
(v) 
Moderate 
Male            
   N 332 59 8         
   Mean (SD) 86.62  (.66) 
77.8  
(1.57) 
55.85  
(4.26)  36.837 < 0.001 .072  *** *** *** 
Female            
   N 316 199 42         
   Mean (SD) 83.78  (.68) 
78.22  
(.85) 
71.4  
(1.86)  27.026 < 0.001 .054  *** *** ** 
Note. post-hoc comparisons were evaluated using Tukey HSD and are marked according to the degree of significant difference. 
The mean difference was significant at the .05 level.  
⁎ p < .05. ⁎⁎ p < .01. ⁎⁎⁎ p < .001. 
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